港股生物医药股盘初拉升，再鼎医药(09688.HK)涨超8.5%，科伦博泰生物(06990.HK)涨近6%，百济神州(06160.HK)涨超4%，荣昌生物(09995.HK)、药明生物(02269.HK)、诺诚健华(09969.HK)、药明康德(02359.HK)等均涨超3%。

Group 1 - Hong Kong biopharmaceutical stocks experienced a significant rise in early trading, with Zai Lab (09688.HK) increasing by over 8.5% [1] - Kelun-Biotech (06990.HK) saw a nearly 6% increase, while BeiGene (06160.HK) rose by over 4% [1] - Other companies such as Rongchang Biologics (09995.HK), WuXi Biologics (02269.HK), Innovent Biologics (09969.HK), and WuXi AppTec (02359.HK) all recorded gains of over 3% [1]